Record NNP B-NP O
date NN I-NP O
: : O O
2076-02-17 CD O B-DATE
Internal NNP B-NP O
Medicine NNP I-NP O
Admission NNP I-NP O
Note NNP I-NP O
Patient NNP B-NP O
Name NN I-NP O
: : O O
Rivers NNS B-NP I-PATIENT
, , O I-PATIENT
Karsten . O I-PATIENT
MRN NNP B-NP O
( -LRB- I-NP O
HH NNP I-NP B-HOSPITAL
) -RRB- I-NP O
: : O O
32054233 CD O B-MEDICALRECORD
Attending VBG B-VP O
: : O O
Dr. NNP B-NP O
Gilmore NNP I-NP B-DOCTOR
CC NNP B-NP O
Ulcer NNP I-NP O
on IN B-PP O
right JJ B-NP O
outer JJ I-NP O
foot NN I-NP O
x NN I-NP O
2 CD B-NP O
days NNS I-NP O
HPI . O O
49 CD B-NP B-AGE
year NN I-NP O
old JJ I-NP O
man NN I-NP O
with IN B-PP O
longstanding JJ B-NP O
diabetes NNS I-NP O
and CC I-NP O
neuropathy NN I-NP O
presented VBN B-VP O
to TO I-VP O
HH VB I-VP B-HOSPITAL
ED VBN I-VP O
for IN B-PP O
right JJ B-NP O
foot NN I-NP O
ulcer NN I-NP O
. . O O
Patient NNP B-NP O
reports VBZ B-VP O
that IN B-NP O
2 CD I-NP O
days NNS I-NP O
ago RB B-ADVP O
, , O O
when WRB B-ADVP O
he PRP B-NP O
clean VB B-VP O
his PRP$ B-NP O
feet NNS I-NP O
, , O O
he PRP B-NP O
noticed VBD B-VP O
a DT B-NP O
piece NN I-NP O
of IN B-PP O
skin NN B-NP O
detached VBN B-VP O
from IN B-PP O
his PRP$ B-NP O
right JJ I-NP O
outer JJ I-NP O
foot NN I-NP O
. . O O
He PRP B-NP O
removed VBD B-VP O
the DT B-NP O
skin NN I-NP O
and CC O O
cleaned VBD B-VP O
the DT B-NP O
wound NN I-NP O
with IN B-PP O
alcohol NN B-NP O
swab NN I-NP O
and CC O O
dressed VBN B-VP O
with IN B-PP O
bind NN B-NP O
aid NN I-NP O
. . O O
He PRP B-NP O
did VBD B-VP O
not RB I-VP O
note VB I-VP O
any DT B-NP O
injury NN I-NP O
to TO B-PP O
his PRP$ B-NP O
foot NN I-NP O
, , O O
did VBD B-VP O
not RB I-VP O
find VB I-VP O
any DT B-NP O
foreign JJ I-NP O
object NN I-NP O
in IN B-PP O
his PRP$ B-NP O
shoes NNS I-NP O
. . O O
He PRP B-NP O
does VBZ B-VP O
recall VB I-VP O
that IN B-PP O
5 CD B-NP O
days NNS I-NP O
ago RB B-ADVP O
, , O O
his PRP$ B-NP O
daughter NN I-NP O
broke VBD B-VP O
a DT B-NP O
vase NN I-NP O
but CC O O
he PRP B-NP O
did VBD B-VP O
not RB I-VP O
step VB I-VP O
on IN B-PP O
it PRP B-NP O
. . O O
The DT B-NP O
next JJ I-NP O
day NN I-NP O
, , O O
he PRP B-NP O
noticed VBD B-VP O
right JJ B-NP O
groin NN I-NP O
pain NN B-NP O
and CC I-NP O
felt VBD B-VP O
a DT B-NP O
lump NN I-NP O
in IN B-PP O
the DT B-NP O
area NN I-NP O
. . O O
The DT B-NP O
right JJ I-NP O
foot NN I-NP O
became VBD B-VP O
warmer RBR B-ADVP O
and CC I-ADVP O
more RBR I-ADVP O
painful JJ I-ADVP O
. . O O
He PRP B-NP O
however RB B-ADVP O
denies VBZ B-VP O
any DT B-NP O
chills NNS I-NP O
, , O O
fever NN B-NP O
, , I-NP O
shaking VBG I-NP O
or CC I-NP O
diaphoresis NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
diagnosed VBN I-VP O
with IN B-PP O
DM NNP B-NP O
for IN B-PP O
more JJR B-NP O
than IN I-NP O
20 CD I-NP O
years NNS I-NP O
, , O O
was VBD B-VP O
on IN B-PP O
insulin NN B-NP O
and CC O O
had VBD B-VP O
constant JJ B-NP O
high JJ I-NP O
blood NN I-NP O
glucose NN I-NP O
( -LRB- I-NP O
&gt JJ I-NP O
;600 NN I-NP O
) -RRB- I-NP O
most JJS I-NP O
of IN B-PP O
the DT B-NP O
time NN I-NP O
before IN B-PP O
the DT B-NP O
gastric JJ I-NP O
bypass NN I-NP O
surgery NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
neuropathy RB O O
for IN B-PP O
more JJR B-NP O
than IN I-NP O
10 CD I-NP O
years NNS I-NP O
. . O O
He PRP B-NP O
had VBD B-VP O
laparoscopic JJ B-NP O
Roux-en-Y NNP I-NP O
on IN B-PP O
06/08/2074 CD B-NP B-DATE
. . O O
His PRP$ B-NP O
weight NN I-NP O
lost VBN B-VP O
from IN B-PP O
435 CD B-NP O
lbs NNS I-NP O
before IN B-PP O
the DT B-NP O
Sx NNP I-NP O
to TO B-PP O
275 CD B-NP O
lbs NNS I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
no RB B-ADVP O
longer RB I-ADVP O
on IN B-PP O
insulin NN B-NP O
. . O O
Current JJ B-NP O
hypoglycemic JJ I-NP O
regimen NN I-NP O
includes VBZ B-VP O
metformin NN B-NP O
850 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
. . I-NP O
Last JJ I-NP O
A1C NNP I-NP O
was VBD B-VP O
less JJR B-ADJP O
than IN B-PP O
7. DT B-NP O
He PRP B-NP O
reports VBZ B-VP O
dry JJ B-NP O
cough NN I-NP O
and CC O O
he PRP B-NP O
attributes VBZ B-VP O
to TO I-VP O
lisinopril VB I-VP O
. . O O
In IN B-PP O
ED NNP B-NP O
, , O O
he PRP B-NP O
was VBD B-VP O
given VBN I-VP O
morphine NN B-NP O
for IN B-PP O
pain NN B-NP O
and CC I-NP O
vancomycin NN I-NP O
iv NN I-NP O
for IN B-PP O
infection NN B-NP O
. . O O
Blood NN B-NP O
culture NN I-NP O
sent VBD B-VP O
before IN B-PP O
given VBN B-NP O
antibiotics NNS I-NP O
. . O O
PMH . O O
DM . O O
Obesity NN B-NP O
s/p NN I-NP O
Roux-en-Y . O O
Right RB B-ADVP O
renal JJ B-NP O
cancer NN I-NP O
s/p VBP B-VP O
partial JJ B-NP O
nephrectomy NN I-NP O
HTN . O O
Diabetic NNP B-NP O
neuropathy NN I-NP O
Family NNP B-NP O
History NN I-NP O
: : O O
Renal NNP B-NP O
failure NN I-NP O
in IN B-PP O
father NN B-NP O
Habits PRP$ O O
Denies NNS B-NP O
smoking NN I-NP O
, , O O
ex-smoker NN B-NP O
, , O O
quit VBD B-VP O
6 CD B-NP O
years NNS I-NP O
ago IN O O
Social NNP B-NP O
ETOH NNP I-NP O
Denies NNS B-NP O
recreational JJ I-NP O
drugs NNS I-NP O
Social NNP B-NP O
History NNP I-NP O
: : O O
Occupation NNP B-NP O
Floor NNP I-NP B-PROFESSION
Covering NNP I-NP I-PROFESSION
Installer NNP I-NP I-PROFESSION
Married VBN B-VP O
, , O O
lives VBZ B-VP O
with IN B-PP O
spouse NN B-NP O
and CC I-NP O
children NNS I-NP O
Medications NNS B-NP O
Caltrate NNP B-NP O
Plus CC I-NP O
D(600MG/400IU) NNP I-NP O
( -LRB- B-VP O
CALCIUM NNP B-NP O
600mg CD I-NP O
+ IN B-PP O
Vitamin JJ B-NP O
D(400IU) JJ I-NP O
) -RRB- I-NP O
1 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
Labetalol NNP B-NP O
Hcl NNP I-NP O
300 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
300MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNP I-NP O
x NN I-NP O
90 CD B-NP O
days NNS I-NP O
# # O O
180 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Lasix NNP B-NP O
( -LRB- I-NP O
FUROSEMIDE NNP I-NP O
) -RRB- I-NP O
80 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
80 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNP B-PP O
# # B-NP O
1 CD I-NP O
Month( JJ B-ADJP O
s PRP B-PP O
) -RRB- B-NP O
Supply NN I-NP O
Lisinopril NNP B-NP O
20 CD I-NP O
MG NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD NNP I-NP O
# # I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Miconazole NNP B-NP O
Nitrate NNP I-NP O
2 CD I-NP O
% NN I-NP O
Powder NN I-NP O
1 CD I-NP O
APPLICATION NN I-NP O
( -LRB- I-NP O
2 CD I-NP O
% NN I-NP O
POWDER NN I-NP O
) -RRB- I-NP O
TOP NNP I-NP O
TID NNP B-PP O
# # B-NP O
1 CD I-NP O
month( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
SupplyOmeprazole NNP I-NP O
20 CD I-NP O
MG NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
MG NNP I-NP O
CAPSULE NNP I-NP O
DR NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
BID NNP B-NP O
#60 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Allergies . O O
Penicillins NNP B-NP O
- : O O
Rash NN B-NP O
ROS NNS B-NP O
Negative JJ B-NP O
except IN I-NP O
noted VBN B-VP O
in IN B-PP O
HPI NNP B-NP O
Physical JJ B-NP O
Examination NN I-NP O
Vitals NNS B-NP O
: : O O
BP NNP B-NP O
142/67 CD I-NP O
, , O O
HR NNP B-NP O
87 CD I-NP O
, , O O
R NN B-NP O
18 CD I-NP O
, , O O
T NNP B-NP O
99 CD I-NP O
, , O O
O2 NNP B-NP O
sat VBD B-VP O
99 CD B-NP O
rm NN I-NP O
air NN I-NP O
Patient NNP B-NP O
is VBZ B-VP O
in IN B-PP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
, , O O
good JJ B-NP O
attention NN I-NP O
to TO B-PP O
hygiene NN B-NP O
and CC I-NP O
body NN I-NP O
habitus NN I-NP O
. . O O
Oriented JJ B-ADVP O
to TO B-PP O
person NN B-NP O
, , I-NP O
place NN I-NP O
and CC I-NP O
time NN I-NP O
. . O O
obese VB B-VP O
. . B-NP O
Mood NNP I-NP O
normal JJ I-NP O
and CC I-NP O
appropriate JJ I-NP O
to TO B-PP O
situation NN B-NP O
. . O O
Eyes NNS B-NP O
: : O O
EOMI NN B-NP O
HEENT NNP B-NP O
: : O O
NC/AT NN B-NP O
Neck NNP B-NP O
: : O O
Supple NNP B-NP O
. . O O
No DT B-NP O
JVD. NNP I-NP O
Thyroid NNP I-NP O
is VBZ B-VP O
palpable JJ B-ADJP O
with IN B-PP O
normal JJ B-NP O
size NN I-NP O
and CC I-NP O
consistency NN I-NP O
. . O O
Respiratory NN B-NP O
: : O O
Auscultation NNP B-NP O
of IN B-PP O
lungs NNS B-NP O
reveal VBP B-VP O
clear JJ B-NP O
lung NN I-NP O
fields NNS I-NP O
. . O O
Cardiovascular NNP B-NP O
: : O O
Heart NNP B-NP O
auscultation NN I-NP O
reveals VBZ B-VP O
normal JJ B-NP O
S1 NN I-NP O
and CC O O
S2 NN B-NP O
and CC O O
no DT B-NP O
murmurs NNS I-NP O
. . O O
Abdomen NNP B-NP O
: : O O
Abdomen IN B-PP O
soft JJ B-NP O
, , I-NP O
nontender JJ I-NP O
, , I-NP O
bowel NN I-NP O
sounds VBZ B-VP O
present JJ B-ADJP O
, , O O
no DT B-NP O
palpable JJ I-NP O
masses NNS I-NP O
. . O O
Neurological JJ B-NP O
Examination NNP I-NP O
: : O O
No DT B-NP O
focal JJ I-NP O
deficit NN I-NP O
. . B-NP O
DTR NN I-NP O
WNL . O O
Extremity NNP B-NP O
exam NN I-NP O
: : O O
+Right JJ B-NP O
foot NN I-NP O
shallow JJ I-NP O
ulcer NN I-NP O
with IN B-PP O
right JJ B-NP O
foot NN I-NP O
erythema NN I-NP O
, , O O
warm JJ B-NP O
and CC I-NP O
tender NN I-NP O
. . O O
Right RB O O
groin NN B-NP O
enlarged VBD B-VP O
and CC O O
tender NN B-NP O
lymph NN I-NP O
node NN I-NP O
ResultsDate/Time NN B-NP O
NA NNP I-NP O
K NNP I-NP O
CL VBZ B-VP O
CO2 NNP B-NP O
02/17/2076 CD I-NP B-DATE
137 CD I-NP O
3.8 CD I-NP O
100 CD I-NP O
30 CD I-NP O
( -LRB- I-NP O
H) NNP I-NP O
Date/Time NNP I-NP O
BUN NNP I-NP O
CRE NNP I-NP O
EGFR NNP I-NP O
GLU NNP I-NP O
02/17/2076 CD I-NP B-DATE
24 CD I-NP O
( -LRB- O O
H) NN B-NP O
1.32 CD I-NP O
( -LRB- I-NP O
H) NN I-NP O
&gt NN I-NP O
; : O O
60 CD B-NP O
177 CD I-NP O
( -LRB- I-NP O
H) NNP I-NP O
Date/Time NNP I-NP O
ANION NNP I-NP O
02/17/2076 CD I-NP B-DATE
8 CD I-NP O
Date/Time NNP I-NP O
CA NNP I-NP O
TBILI NNP I-NP O
TP NNP I-NP O
ALB NNP I-NP O
02/17/2076 VBD B-VP B-DATE
9.0 CD B-NP O
0.6 CD I-NP O
6.8 CD I-NP O
4.0 CD I-NP O
Date/Time NN I-NP O
ALT/SGPT NNP I-NP O
AST/SGOT NNP I-NP O
ALKP NNP I-NP O
TBILI NNP I-NP O
02/17/2076 CD I-NP B-DATE
10 CD I-NP O
15 CD I-NP O
110 CD I-NP O
0.6 CD I-NP O
Date/Time NNP I-NP O
UACET NNP I-NP O
02/17/2076 CD I-NP B-DATE
NEGATIVE JJ I-NP O
Date/Time NNP I-NP O
WBC NNP I-NP O
RBC NNP I-NP O
HGB NNP I-NP O
HCT NNP I-NP O
02/17/2076 CD I-NP B-DATE
13.6 CD I-NP O
( -LRB- I-NP O
H) NN I-NP O
4.30 CD I-NP O
( -LRB- I-NP O
L NNP I-NP O
) -RRB- I-NP O
11.9 CD I-NP O
( -LRB- I-NP O
L NNP I-NP O
) -RRB- I-NP O
35.2 CD I-NP O
( -LRB- I-NP O
L NNP I-NP O
) -RRB- I-NP O
Date/Time NNP I-NP O
MCV NNP I-NP O
MCH NNP I-NP O
MCHC NNP I-NP O
PLT NNP I-NP O
02/17/2076 CD I-NP B-DATE
82 CD I-NP O
27.7 CD I-NP O
( -LRB- I-NP O
L NNP I-NP O
) -RRB- I-NP O
33.9 CD I-NP O
237 CD I-NP O
Date/Time NNP I-NP O
RDW NNP I-NP O
02/17/2076 VBD B-VP B-DATE
13.4 CD B-NP O
Date/Time NNP I-NP O
%NEUT NNP I-NP O
%MONO NNP I-NP O
%EOS NNP I-NP O
%BASO NNP I-NP O
02/17/2076 CD I-NP B-DATE
82.0 CD I-NP O
( -LRB- B-PP O
H) RB B-NP O
4.1 CD I-NP O
1.4 CD I-NP O
0.3 CD I-NP O
Date/Time NNP I-NP O
%LYMPH-M NNP I-NP O
02/17/2076 CD I-NP B-DATE
12.2 CD I-NP O
( -LRB- I-NP O
L NNP I-NP O
) -RRB- I-NP O
Date/Time NNP I-NP O
UA-COLOR NNP I-NP O
UA-APP NNP I-NP O
UA-GLUC NNP I-NP O
UA-BIL NNP I-NP O
I PRP B-NP O
02/17/2076 VBP B-VP B-DATE
YELLOW NNP B-NP O
CLEAR NN I-NP O
NEGATIVE JJ I-NP O
NEGATIVE JJ I-NP O
Date/Time NNP I-NP O
UR-SPGR NNP I-NP O
UA-BLD NNP I-NP O
UA-PH NNP I-NP O
UA-PROT NNP I-NP O
02/17/2076 CD I-NP B-DATE
1.019 CD I-NP O
NEGATIVE JJ I-NP O
5.0 CD I-NP O
TRACE NN I-NP O
( -LRB- I-NP O
H) NNP I-NP O
Date/Time NNP I-NP O
UA-UROBI NNP I-NP O
UA-NIT NNP I-NP O
UA-WBC NNP I-NP O
02/17/2076 CD I-NP B-DATE
1.0 CD I-NP O
NEGATIVE JJ I-NP O
NEGATIVE JJ I-NP O
EKG NNP I-NP O
: : O O
NSR NNP B-NP O
at IN B-PP O
77 CD B-NP O
BPM. NNP I-NP O
No DT B-NP O
st NN I-NP O
elevation NN I-NP O
CXR NNP B-NP O
: : O O
No DT B-NP O
infiltrates NNS I-NP O
Right RB B-ADVP O
foot NN B-VP O
x-ray NN B-NP O
: : O O
No DT B-NP O
sigh NN I-NP O
suggest VB B-VP O
osteomyelitis NN O O
Assessment NNP B-NP O
: : O O
49 CD B-NP B-AGE
year NN I-NP O
old JJ I-NP O
male NN I-NP O
with IN B-PP O
longstanding JJ B-NP O
DM NNP I-NP O
and CC I-NP O
diabetic JJ I-NP O
neuropathy NN I-NP O
presents NNS I-NP O
with IN B-PP O
new JJ B-NP O
onset RB I-NP O
right JJ I-NP O
foot NN I-NP O
ulcer NN I-NP O
and CC O O
right JJ B-NP O
groin NN I-NP O
lymph NN I-NP O
node NN I-NP O
enlargement NN I-NP O
. . O O
WBC '' O O
is VBZ B-VP O
elevated VBN I-VP O
. . O O
He PRP B-NP O
likely RB B-ADVP O
has VBZ B-VP O
diabetic JJ B-NP O
foot NN I-NP O
ulcer NN I-NP O
and CC I-NP O
foot NN I-NP O
cellulitis NN I-NP O
. . B-NP O
X-ray NN I-NP O
dose NN I-NP O
not RB O O
suggest VB B-VP O
osteomyelitis NN B-NP O
. . O O
Plan NNP B-NP O
: : O O
# # B-NP O
1 CD I-NP O
) -RRB- I-NP O
Diabetic JJ I-NP O
foot NN I-NP O
ulcer NN I-NP O
and CC I-NP O
cellulitis NN I-NP O
: : O O
given VBN B-VP O
his PRP$ B-NP O
risk NN I-NP O
for IN B-PP O
polymicrobial NN B-NP O
infection NN I-NP O
, , O O
will MD B-VP O
cover VB I-VP O
with IN B-PP O
broad JJ B-NP O
spectrum NN I-NP O
antibiotics NNS I-NP O
for IN B-PP O
aerobes NNS B-NP O
and CC I-NP O
anaerobes NNS I-NP O
plus CC O O
MRSA NNP B-NP O
. . O O
-Vancomycin NNP B-NP O
1 CD I-NP O
gm NN I-NP O
iv NN I-NP O
daily RB O O
-Zosyn JJ B-NP O
4.5 CD I-NP O
gm NN I-NP O
iv FW I-NP O
q6H FW O O
-F/U JJ B-NP O
blood NN I-NP O
culture NN I-NP O
-Pain JJ B-NP O
management NN I-NP O
-IV NNP B-NP O
NS NNS I-NP O
75 CD B-NP O
ml/hr NN I-NP O
# # B-NP O
2 CD I-NP O
) -RRB- I-NP O
DM NNP I-NP O
, , O O
well RB B-VP O
controlled VBN I-VP O
with IN B-PP O
metformin NN B-NP O
after IN B-PP O
gastric JJ B-NP O
bypass NN I-NP O
. . O O
-Hold JJ B-NP O
metformin NN I-NP O
-NPH NNP B-NP O
5 CD I-NP O
u NN I-NP O
SC NNP I-NP O
BID NNP I-NP O
-Low JJ B-NP O
scale NN I-NP O
SS NNP I-NP O
-FS NNS B-NP O
qAC NNS I-NP O
3# JJ B-NP O
) -RRB- I-NP O
HTN NNP I-NP O
, , O O
on IN B-PP O
lisinopril NN B-NP O
and CC O O
developed VBD B-VP O
dry JJ B-NP O
cough NN I-NP O
-d/c JJ B-NP O
lisinopril NN I-NP O
, , O O
start VB B-VP O
Cozaar NNP B-NP O
50 CD I-NP O
mg NN I-NP O
daily RB B-ADVP O
-Continue JJ B-NP O
labetalol JJ I-NP O
300mg JJ I-NP O
bid NN I-NP O
-hold JJ B-NP O
lasix NN I-NP O
DVT NNP B-NP O
prophylaxis NNS I-NP O
Code NNP B-NP O
Full NNP I-NP O
Ollie NNP B-NP B-DOCTOR
Kern NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
